These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8999671)

  • 61. Clinical and virological course of chronic hepatitis B virus infection with hepatitis C and D virus markers.
    Liaw YF; Tsai SL; Sheen IS; Chao M; Yeh CT; Hsieh SY; Chu CM
    Am J Gastroenterol; 1998 Mar; 93(3):354-9. PubMed ID: 9517639
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Alpha 2 recombinant interferon in the treatment of chronic hepatitis delta virus (HDV) hepatitis.
    Rosina F; Saracco G; Lattore V; Quartarone V; Rizzetto M; Verme G; Trinchero P; Sansalvadore F; Smedile A
    Prog Clin Biol Res; 1987; 234():299-303. PubMed ID: 3628384
    [No Abstract]   [Full Text] [Related]  

  • 63. High HBsAg and anti-delta carrier rate among asymptomatic Africans living on the campus of the University of Niamey, Niger.
    Soubiran G; Le Bras M; Marini P; Sekou H
    Trans R Soc Trop Med Hyg; 1987; 81(6):998-1000. PubMed ID: 3503422
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients.
    Raimondo G; Brunetto MR; Pontisso P; Smedile A; Maina AM; Saitta C; Squadrito G; Tono N;
    Hepatology; 2006 Jan; 43(1):100-7. PubMed ID: 16323213
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prevalence of anti-delta antibodies in pregnant women in Bandung, Indonesia.
    Vranckx R; Reniers J; Alisjahbana A; Ngantung W; Sugita E; Meheus A
    Trop Geogr Med; 1988 Jan; 40(1):17-9. PubMed ID: 3381311
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Perinatal transmission of hepatitis B virus-associated hepatitis D virus.
    Ramia S; Bahakim H
    Ann Inst Pasteur Virol; 1988; 139(3):285-90. PubMed ID: 3207507
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evolutionary trends in the prevalence of anti-HDV antibodies among patients positive for HBsAg referred to a national laboratory in Cameroon from 2012 to 2017.
    Noubissi-Jouegouo L; Atsama MA; Tagnouokam-Ngoupo PA; Monamele CG; Ngono L; Njouom R
    BMC Res Notes; 2019 Jul; 12(1):417. PubMed ID: 31307546
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Low-level viremia and intracellular expression of hepatitis B surface antigen (HBsAg) in HBsAg carriers with concurrent hepatitis C virus infection.
    Chu CM; Yeh CT; Liaw YF
    J Clin Microbiol; 1998 Jul; 36(7):2084-6. PubMed ID: 9650968
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Alpha interferon therapy of chronic delta hepatitis: a pilot study.
    Di Bisceglie AM; Negro F; Smedile A; Bergmann K; Hoofnagle JH
    Prog Clin Biol Res; 1991; 364():393-7. PubMed ID: 2020714
    [No Abstract]   [Full Text] [Related]  

  • 70. Hepatitis B liver disease in cyclosporine-treated renal allograft recipients.
    Huang CC; Lai MK; Fong MT
    Transplantation; 1990 Mar; 49(3):540-4. PubMed ID: 2316016
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Infection due to hepatitis delta virus in Africa: report from Senegal and review.
    Roingeard P; Sankalé JL; Dubois F; Diouf A; Bacha A; Mboup S; Goudeau A
    Clin Infect Dis; 1992 Feb; 14(2):510-4. PubMed ID: 1554840
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The relationships of chronic hepatitis and cirrhosis to alcohol intake, hepatitis B and C, and delta virus infection: a case-control study in Albania.
    Kondili LA; Tosti ME; Szklo M; Costantino A; Cotichini R; Resuli B; Rapicetta M; Mele A
    Epidemiol Infect; 1998 Oct; 121(2):391-5. PubMed ID: 9825791
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Concurrent hepatitis C virus and hepatitis delta virus superinfection in patients with chronic hepatitis B virus infection.
    Liaw YF; Chien RN; Chen TJ; Sheen IS; Chu CM
    J Med Virol; 1992 Aug; 37(4):294-7. PubMed ID: 1402827
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Serologic markers of viral hepatitis A, B, C, and D in patients with hemophilia.
    Kumar A; Kulkarni R; Murray DL; Gera R; Scott-Emuakpor AB; Bosma K; Penner JA
    J Med Virol; 1993 Nov; 41(3):205-9. PubMed ID: 8263502
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Fulminant hepatitis due to HBV/HDV coinfection.
    Koff RS
    Hosp Pract (Off Ed); 1987 Nov; 22(11):123-30, 139-40, 145-50 passim. PubMed ID: 3119612
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Interactions between hepatotropic viruses in patients with haemophilia.
    Lee CA; Kernoff PB; Karayiannis P; Farci P; Thomas HC
    J Hepatol; 1985; 1(4):379-84. PubMed ID: 3932510
    [TBL] [Abstract][Full Text] [Related]  

  • 77. HBV/HDV coinfection.
    Caredda F; Antinori S; Pastecchia C; Moroni M
    Lancet; 1987 Aug; 2(8556):455. PubMed ID: 2887756
    [No Abstract]   [Full Text] [Related]  

  • 78. Clearance of hepatitis B surface antigen in chronic carriers of hepatitis delta antibodies.
    Niro GA; Gravinese E; Martini E; Garrubba M; Facciorusso D; Conoscitore P; Di Giorgio G; Rizzetto M; Andriulli A
    Liver; 2001 Aug; 21(4):254-9. PubMed ID: 11454188
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Delta hepatitis].
    Goudeau A; Dubois F; Leturcq P
    Presse Med; 1987 Dec; 16(42):2117-22. PubMed ID: 2963285
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prevalence of anti-delta antibodies in chronic HBsAg carriers in Czechoslovakia.
    Stránský J; Jezek P; Zichová M; Kolácný I; Horák Z; Vodák M; Chalupa P
    Infection; 1989; 17(4):252. PubMed ID: 2788620
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.